![Xenon Pharmaceuticals Inc](/common/images/company/N_XENE.png)
Xenon Pharmaceuticals Inc (XENE)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -34.993 | -54.053 | -40.934 | -30.797 | -16.631 | -20.254 | -18.842 | -21.222 |
Return on Equity (%) | -36.814 | -61.509 | -49.554 | -42.602 | -21.276 | -21.372 | -19.651 | -22.116 |
Return on Invested Capital (%) | -40.211 | -61.87 | -47.485 | -38.905 | -23.055 | -22.281 | -23.172 | -35.869 |
Operating Margin (%) | -1275.485 | -9872.669 | N/A | -588.432 | -88.945 | -427.879 | -1327.698 | N/A |
Net Profit Margin (%) | -1275.485 | -9872.669 | N/A | -609.094 | -87.089 | -418.11 | -1324.316 | N/A |
Book Value Per Share | 3.564 | 1.997 | 3.711 | 2.89 | 4.542 | 10.3 | 11.528 | 12.312 |
Earnings Per Share | -1.283 | -1.706 | -1.34 | -1.427 | -0.778 | -1.464 | -1.996 | -2.42 |
Cash Per Share | 0.953 | 1.138 | 2.631 | 0.849 | 1.249 | 3.337 | 0.915 | 1.972 |
Working Capital Per Share | 3.467 | 2.263 | 4.556 | 3.481 | 4.635 | 10.345 | 9.229 | 8.195 |
Operating Profit Per Share | 0.101 | 0.017 | N/A | 0.234 | 0.893 | 0.35 | 0.151 | N/A |
EBIT Per Share | -1.283 | -1.706 | -1.34 | -1.427 | -0.808 | -1.498 | -2.001 | -2.424 |
EBITDA Per Share | -1.283 | -1.706 | -1.34 | -1.427 | -0.808 | -1.498 | -2.001 | -2.424 |
Free Cash Flow Per Share | -1.315 | -1.725 | -1.343 | -1.399 | -0.722 | -1.442 | -1.976 | -2.392 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 17,93M | 18M | 25,75M | 28,14M | 35,01M | 51,64M | 62,59M | 75,37M |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 62,54M | 62,59M | 63,11M | 63,72M | 65M | 75,37M | 75,46M | 75,67M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 3,01B |
Ratio cours/bénéfice | -16,42 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 20,15 |
Ratio prix/valeur comptable | 3,23 |
Rendement de dividende | - |
Actions en circulation | 76,24M |
Volume moyen (1 semaine) | 366,09k |
Volume moyen (1 mois) | 417,62k |
Variation sur 52 semaines | -17,74% |
Plus haut sur 52 semaines | 50,99 |
Plus bas sur 52 semaines | 35,53 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales